Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM

[1]  L. Groop,et al.  Changes of lipolytic enzymes cluster with insulin resistance syndrome , 1995, Diabetologia.

[2]  M. Laakso,et al.  Microalbuminuria Precedes the Development of NIDDM , 1994, Diabetes.

[3]  R. Heine,et al.  Determinants of insulin sensitivity and consequences for lipoproteins and blood pressure in subjects with non-insulin-dependent diabetes mellitus. , 1994, Metabolism: clinical and experimental.

[4]  A. Solini,et al.  Impaired Insulin-Induced Glucose Uptake by Extrahepatic Tissue Is Hallmark of NIDDM Patients Who Have or Will Develop Hypertension and Microalbuminuria , 1994, Diabetes.

[5]  L. Niskanen,et al.  Insulin resistance is related to albuminuria in patients with type II (non-insulin-dependent) diabetes mellitus. , 1993, Metabolism: clinical and experimental.

[6]  R. Trevisan,et al.  Insulin resistance in insulin-dependent diabetic patients with microalbuminuria , 1993, The Lancet.

[7]  S. Bain,et al.  Microalbuminuria and insulin resistance in diabetes mellitus , 1993, The Lancet.

[8]  S. Grundy,et al.  Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[9]  L. Groop,et al.  Insulin resistance, hypertension and microalbuminuria in patients with Type 2 (non-insulin-dependent) diabetes mellitus , 1993, Diabetologia.

[10]  G. Ginsburg,et al.  High-density lipoprotein subfractions. , 1993, The American journal of medicine.

[11]  H. Ginsberg,et al.  Increased production rates of LDL are common in individuals with low plasma levels of HDL cholesterol, independent of plasma triglyceride concentrations. , 1993, Arteriosclerosis and Thrombosis A Journal of Vascular Biology.

[12]  I. Goldberg,et al.  Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol. , 1993, The Journal of clinical investigation.

[13]  R. Taylor,et al.  Abnormal Activation of Glycogen Synthesis in Fibroblasts from NIDDM Subjects: Evidence for an Abnormality Specific to Glucose Metabolism , 1993, Diabetes.

[14]  A. Jonas,et al.  Structural properties of high density lipoprotein subclasses homogeneous in protein composition and size. , 1993, The Journal of biological chemistry.

[15]  J. Yudkin,et al.  Microalbuminuria: associations with height and sex in non-diabetic subjects. , 1993, BMJ.

[16]  L. Groop,et al.  Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[17]  A. Franssila-Kallunki.  Comparison of near-infrared light spectroscopy, bioelectrical impedance and tritiated water techniques for the measurement of fat-free mass in humans. , 1992, Scandinavian journal of clinical and laboratory investigation.

[18]  S. Grundy,et al.  Physiologic mechanisms for reduced apolipoprotein A-I concentrations associated with low levels of high density lipoprotein cholesterol in patients with normal plasma lipids. , 1992, Journal of lipid research.

[19]  I. Godsland,et al.  Influence of insulin resistance, secretion, and clearance on serum cholesterol, triglycerides, lipoprotein cholesterol, and blood pressure in healthy men. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[20]  S. Haffner,et al.  Prospective analysis of the insulin-resistance syndrome (syndrome X). , 1992, Diabetes.

[21]  A. Fitzgerald,et al.  Prospective Study of Microalbuminuria as Predictor of Mortality in NIDDM , 1992, Diabetes.

[22]  L. Groop,et al.  Impaired Activation of Glycogen Synthase in People at Increased Risk for Developing NIDDM , 1992, Diabetes.

[23]  K. Alberti,et al.  Microalbuminuria and associated cardiovascular risk factors in the community. , 1992, Atherosclerosis.

[24]  A. Vaag,et al.  Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. , 1992, The Journal of clinical investigation.

[25]  D. Johnston,et al.  The Role of Insulin Insensitivity and Hepatic Lipase in the Dyslipidaemia of Type 2 Diabetes , 1991, Diabetic medicine : a journal of the British Diabetic Association.

[26]  S. Eisenberg,et al.  Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia. , 1991, The Journal of clinical investigation.

[27]  J. Clore,et al.  Increased Transcapillary Escape Rate of Albumin in Nondiabetic Men in Response to Hyperinsulinemia , 1990, Diabetes.

[28]  S. Haffner,et al.  Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects? , 1990, Arteriosclerosis.

[29]  A Tremblay,et al.  Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. , 1990, Arteriosclerosis.

[30]  L. Groop,et al.  Urinary excretion of kappa light chains in patients with diabetes mellitus. , 1990, Kidney international.

[31]  C. Mogensen,et al.  Microalbuminuria as predictor of increased mortality in elderly people. , 1990, BMJ.

[32]  R G Shulman,et al.  Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. , 1990, The New England journal of medicine.

[33]  L. Groop,et al.  Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. , 1989, The New England journal of medicine.

[34]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[35]  P. Raskin,et al.  Relationship between lipoprotein levels and in vivo insulin action in normal young white men. , 1988, Metabolism: clinical and experimental.

[36]  C. Jackson,et al.  MICROALBUMINURIA AS PREDICTOR OF VASCULAR DISEASE IN NON-DIABETIC SUBJECTS Islington Diabetes Survey , 1988, The Lancet.

[37]  E. Ferrannini.  The theoretical bases of indirect calorimetry: a review. , 1988, Metabolism: clinical and experimental.

[38]  A. Schmitz,et al.  Microalbuminuria: A Major Risk Factor in Non‐insulin‐dependent Diabetes. A 10‐year Follow‐up Study of 503 Patients , 1988, Diabetic medicine : a journal of the British Diabetic Association.

[39]  H. Keen,et al.  Coronary heart disease and urinary albumin excretion rate in Type 2 (non-insulin-dependent) diabetic patients , 1988, Diabetologia.

[40]  C Bogardus,et al.  Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. , 1987, The Journal of clinical investigation.

[41]  S. Lillioja,et al.  Relationships Between Plasma Lipoprotein Concentrations and Insulin Action in an Obese Hyperinsulinemic Population , 1987, Diabetes.

[42]  K. Borch-Johnsen,et al.  Coronary heart disease in young Type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors , 1987, Diabetologia.

[43]  G. Viberti,et al.  Microalbuminuria Predicts Mortality in Noninsulin‐dependent Diabetes , 1984, Diabetic medicine : a journal of the British Diabetic Association.

[44]  A. Teppo.  Immunoturbidimetry of albumin and immunoglobulin G in urine. , 1982, Clinical chemistry.

[45]  J W Rowe,et al.  Effect of Insulin and Glucose Infusions on Sympathetic Nervous System Activity in Normal Man , 1981, Diabetes.

[46]  M Halperin,et al.  Correlations of Plasma High‐density Lipoprotein Cholesterol Levels with Other Plasma Lipid and Lipoprotein Concentrations: The Lipid Research Clinics Program Prevalence Study , 1980, Circulation.

[47]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.

[48]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[49]  G. Striker.  Glucose toxicity. , 2001, Kidney international.

[50]  R. DeFronzo,et al.  The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. , 1992, Diabetes.

[51]  M. Austin.  Plasma triglyceride and coronary heart disease. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[52]  M. Saad,et al.  Insulin resistance in essential hypertension. , 1990, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.